Limited efficacy of adalimumab in the acute phase of serpiginous choroiditis refractory to corticosteroid and cyclosporine, a case report
Pre-publication versions of this article are available by contacting email@example.com.
|4 Jan 2019||Submitted||Original manuscript|
|28 Jan 2019||Reviewed||Reviewer Report - Pradeep Venkatesh|
|28 Jan 2019||Reviewed||Reviewer Report - Ryoji Yanai|
|9 Feb 2019||Reviewed||Reviewer Report - Nikolaos Theodor Voutsas|
|13 Feb 2019||Reviewed||Reviewer Report - Ariel Schlaen|
|3 Mar 2019||Author responded||Author comments - Kazunori Noda|
|Resubmission - Version 2|
|3 Mar 2019||Submitted||Manuscript version 2|
|17 Mar 2019||Reviewed||Reviewer Report - Ryoji Yanai|
|27 Mar 2019||Reviewed||Reviewer Report - Ariel Schlaen|
|4 Apr 2019||Author responded||Author comments - Kazunori Noda|
|Resubmission - Version 3|
|4 Apr 2019||Submitted||Manuscript version 3|
|9 Apr 2019||Editorially accepted|
|24 Apr 2019||Article published||10.1186/s12886-019-1104-3|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting firstname.lastname@example.org.
You can find further information about the peer review system here.